Press Release | Bentham Science journals improve impact factor ratings in 2019

 

The latest edition of Journal Citation Reports® 2019 has been published recently, and according to the report, Bentham Science Publishers (BSP) journals have significantly improved their Impact Factors. Current Neuropharmacology is leading the list again with the highest impact factor (IF: 4.568) among all the journals. In total, 40 BSP journals have received Impact Factor ratings this year. The latest results in the JCR 2019 reflect the high quality of research published by Bentham Science.

Journal Citation Reports (JCR) is an annual publication by Clarivate Analytics. JCR has been integrated with the Web of Science and is accessible from the Web of Science-Core Collections. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data.

Bentham Science publishes over 100 print & online scholarly subscription journals and books. Learn more about Bentham Science here: http://www.benthamscience.com

 

Read full press release to find out more at: https://www.eurekalert.org/pub_releases/2019-06/bsp-bsl062019.php

Wishing you a very Happy Birthday | Prof. George Perry

 

Prof-George-Perry

 

Prof. George Perry

Editor in Chief: Mini-Reviews in Medicinal Chemistry

College of Sciences
The University of Texas at San Antonio
Texas
USA

New Issues of various Bentham Science Journals

 

1. Mini-Reviews in Medicinal Chemistry, Vol: 18, Issue: 16

https://bit.ly/2qCXROI

2. Mini-Reviews in Medicinal Chemistry, Vol: 18, Issue: 17

https://bit.ly/2qBcaDd

3. Current Drug Targets, Vol: 19, Issue: 13

https://bit.ly/2QttYLL

4. Current Drug Metabolism, Vol: 19, Issue: 10

https://bit.ly/2qAdypw

5. Current Cancer Drug Targets, Vol: 18, Issue: 8

https://bit.ly/2z3e6sN

6. Current Pharmaceutical Analysis, Vol: 14, Issue: 6

https://bit.ly/2PNXYVE

7. The Natural Products Journal, Vol: 8, Issue: 3

https://bit.ly/2yYGJY6

8. Current Organocatalysis, Vol: 5, Issue: 2

https://bit.ly/2RKY65t

9. Current Drug Safety, Vol: 13, Issue: 3

https://bit.ly/2OvKMjC

10. Current Topics in Medicinal Chemistry, Vol: 18, Issue: 12

https://bit.ly/2D9ecSA

 

Issues

New Issues of various Bentham Science Journals

 

1. Cardiovascular & Hematological Agents in Medicinal Chemistry, Vol: 16, Issue:1

https://bit.ly/2AWUnwp

2. Letters in Organic Chemistry, Vol: 15, Issue: 10

https://bit.ly/2QCmhCY

3. Current Vascular Pharmacology, Vol: 16, Issue: 6

https://bit.ly/2AVbmiI

4. Current Pharmaceutical Design, Vol: 24, Issue: 17

https://bit.ly/2PSKAzs

5. Recent Patents on Inflammation & Allergy Drug Discovery, Vol: 12, Issue: 2

https://bit.ly/2QrcEqY

6. Current Organic Chemistry, Vol: 22, Issue: 15

https://bit.ly/2SXAnAH

7. Current Pharmaceutical Design, Vol: 24, Issue: 18

https://bit.ly/2PK2qF3

8. Recent Patents on Biotechnology, Vol: 12, Issue: 3

https://bit.ly/2z29KlC

9. Mini-Reviews in Medicinal Chemistry, Vol: 18, Issue: 16

https://bit.ly/2qCXROI

 

 

Issues.jpg

WISHING A VERY HAPPY BIRTHDAY M. IQBAL CHOUDHARY!

Dr iqbal choudhary.jpg

M. IQBAL CHOUDHARY

EDITOR-IN-CHIEF: Mini-Reviews in Medicinal Chemistry

International Center for Chemical and Biological Sciences H. E. J. Research

Institute of Chemistry Dr. Panjwani Center for Molecular Medicine and Drug Research University of Karachi,

Karachi, Pakistan.

AIMS & SCOPE – Mini-Reviews in Medicinal Chemistry

Aims & Scope:

The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Mini-Reviews in Medicinal Chemistry covers all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.

Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

 

mrmc-flyer

 

FOR DETAILS, PLEASE VISIT:  https://benthamscience.com/journals/mini-reviews-in-medicinal-chemistry/aims-scope/#top 

MOST ACCESSED ARTICLE – Recent Progress in Biological Activities of Indole and Indole Alkaloids

Journal Name: Mini-Reviews in Medicinal Chemistry

Author(s): Thokchom Prasanta Singh, Okram Mukherjee Singh*.

 

 

 

 

Graphical Abstract:

 

Abstract:

The indole scaffold is found in a wide range of bioactive heterocycles and natural products. Moreover, the indole moiety is considered as the active principle in several alkaloids such as mitomycin C and reserpine. Thus, over the past decade, chemists are increasingly attracted towards the studies on the pharmacological and therapeutic activities of indole containing compounds. Furthermore, the molecular structures of well-known drugs such as sumatriptan, tadalafil, fluvastatin and rizatriptan are based on indole frameworks.

This mini-review covers some of the significant and recent achievements of indole derivatives with respect to their biological activities up to 2015.

 

READ MORE HERE: http://www.eurekaselect.com/154723

OPEN ACCESS ARTICLE – Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment

Journal Name: Mini-Reviews in Medicinal Chemistry

Author(s): Voon Yee-Lin*, Wong Pooi-Fong , Alan Khoo Soo-Beng

 

 

 

 

Graphical Abstract:

 

Abstract:

Nasopharyngeal carcinoma (NPC) is a form of head and neck cancer of multifactorial etiologies that is highly prevalent among men in the population of Southern China and Southeast Asia. NPC has claimed many thousands of lives worldwide; but the low awareness of NPC remains a hindrance in early diagnosis and prevention of the disease. NPC is highly responsive to radiotherapy and chemotherapy, but radiocurable NPC is still dependent on concurrent treatment of megavoltage radiotherapy with chemotherapy. Despite a significant reduction in loco-regional and distant metastases, radiotherapy alone has failed to provide a significant improvement in the overall survival rate of NPC, compared to chemotherapy. In addition, chemo-resistance persists as the major challenge in the management of metastatic NPC although the survival rate of advanced metastatic NPC has significantly improved with the administration of chemotherapy adjunctive to radiotherapy. In this regard, targeted molecular therapy could be explored for the discovery of alternative NPC therapies. Nutlin-3, a small molecule inhibitor that specifically targets p53-Mdm2 interaction offers new therapeutic opportunities by enhancing cancer cell growth arrest and apoptosis through the restoration of the p53-mediated tumor suppression pathway while producing minimal cytotoxicity and side effects. This review discusses the potential use of Nutlin-3 as a p53-activating drug and the future directions of its clinical research for NPC treatment.

 

READ MORE HERE: http://www.eurekaselect.com/154246 

PRESS RELEASE: BENTHAM SCIENCE JOURNALS – IMPACT FACTORS 2018

News release date: July 11, 2018

 

The latest edition of Journal Citation Reports® 2018 has been recently published, and according to the report, 41 Bentham Science Publishers (BSP) journals have received Impact Factor ratings. Current Neuropharmacology has continued to top the list with the highest impact factor among all Bentham Science Journals. Current Molecular Pharmacology has also joined the BSP High Impact Journals list with its first JCR Impact Factor rating of 2.481.

 

Here are the top 10 high impact factor journals published by Bentham Science:

  1. Current Neuropharmacology
    Impact Factor: 4.068
  2. Current Medicinal Chemistry
    Impact Factor: 3.469
  3. Current Topics in Medicinal Chemistry
    Impact Factor: 3.374
  4. Current Alzheimer Research
    Impact Factor: 3.289
  5. Current Drug Targets
    Impact Factor: 3.112
  6. Current Pharmaceutical Design
    Impact Factor: 2.757
  7. Current Protein & Peptide Science
    Impact Factor: 2.696
  8. Current Drug Metabolism
    Impact Factor: 2.655
  9. Mini-Reviews in Medicinal Chemistry
    Impact Factor: 2.645
  10. Medicinal Chemistry
    Impact Factor: 2.631

 

Journal Citation Reports (JCR) is an annual publication by Clarivate Analytics. JCR has been integrated with the Web of Science and is accessible from the Web of Science-Core Collections. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data.

Bentham Science publishes over 100 print & online scholarly subscription journals and books. Learn more about Bentham Science here.

New Issue :: Mini-Reviews in Medicinal Chemistry 18, Issue 12

The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.

The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.

Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

mrmc-5-4.jpg

 

Articles from the journal Mini-Reviews in Medicinal Chemistry Volume 18, Issue 12:

For details on the articles, please visit this link :: https://bit.ly/2y8EhAj 

%d bloggers like this: